Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chugai Pharmaceutical: To Recall Leukemia Drug In Japan (Japan)

This article was originally published in PharmAsia News

Executive Summary

Chugai Pharmaceutical Co. has started recalling a leukemia drug, Vesanoid, in Japan as a specified batch of the drug from its parent Roche Holding AG contained material that wasn't approved by the Japanese government. The company said capsules of the drug in this particular batch contained bovine-derived material sourced from Canada. Use of the material in question is approved overseas, but it requires special approval from the government in Japan. Roche had thought that the use of the material had been approved by the Japanese government and exported the batch to Japan. Chugai is recalling 1,998 bottles of Vesanoid Capsule shipped to 740 medical institutions between Jan. 5 and June 18 this year. (Click here for more - May Require Paid Subscription
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC066480

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel